Search Result

Results for "

Competative Inhibitors

" in MedChemExpress (MCE) Product Catalog:

By Targets:	Adenylate Cyclase (2) Adrenergic Receptor (2) AIM2 (2) Amino Acid Derivatives (1) Angiotensin-converting Enzyme (ACE) (1) Antibiotic (3) Apoptosis (3) ATM/ATR (1) Autophagy (3) Bacterial (4) Bcl-2 Family (1) c-Met/HGFR (1) Caspase (1) CDK (5) CXCR (2) DGK (1) DNA/RNA Synthesis (1) E1/E2/E3 Enzyme (1) EGFR (1) Endogenous Metabolite (7) Fat Mass and Obesity-associated Protein (FTO) (3) FLAP (1) Gap Junction Protein (5) GSK-3 (2) HIF/HIF Prolyl-Hydroxylase (2) Histone Methyltransferase (3) HIV (3) HSP (2) iGluR (2) Isotope-Labeled Compounds (2) Lipoxygenase (1) mAChR (1) MARCKS (2) MDM-2/p53 (1) Methionine Adenosyltransferase (MAT) (1) MicroRNA (9212) Microtubule/Tubulin (1) nAChR (2) Nucleoside Antimetabolite/Analog (2) P-glycoprotein (1) Phosphoglycerate Dehydrogenase (PHGDH) (2) PKC (2) Potassium Channel (4) SARS-CoV (1) Sodium Channel (1) STING (1) Tie (1) Toll-like Receptor (TLR) (3) TRP Channel (1) Wnt (2) Xanthine Oxidase (1)
By Research Areas:	Cancer (9227) Cardiovascular Disease (3) Endocrinology (3) Infection (8) Inflammation/Immunology (19) Metabolic Disease (5) Neurological Disease (10)
Click Chemistry:	Azide (1)
Oligonucleotides:	miRNA mimics (1) miRNA antagomirs (4605) MicroRNAs (9212) CpG ODNs (1) miRNA inhibitors (4606)

9283

Inhibitors & Agonists

Peptides

Inhibitory Antibodies

Natural
Products

Isotope-Labeled Compounds

Click Chemistry

9213

Oligonucleotides

Targets Recommended: Serpin

Cat. No.	Product Name	Target	Research Areas	Chemical Structure

HY-B0028

Fludarabine phosphate 5 Publications Verification NSC 118218 phosphate	Nucleoside Antimetabolite/Analog Apoptosis	Cancer
Fludarabine (phosphate) is an analogue of adenosine and deoxyadenosine, which is able to compete with dATP for incorporation into DNA and inhibit DNA synthesis.

HY-10006

Flavopiridol Hydrochloride Maximum Cited Publications 42 Publications Verification Alvocidib Hydrochloride; L86-8275 Hydrochloride; HMR-1275 Hydrochloride	CDK Autophagy HIV	Cancer
Flavopiridol Hydrochloride (Alvocidib Hydrochloride) is a broad inhibitor of CDK, competing with ATP to inhibit CDKs including CDK1, CDK2, CDK4 with IC₅₀s of 30, 170, 100 nM, respectively.

HY-15004

AUZ 454 5 Publications Verification K03861	CDK	Cancer
AUZ 454 (K03861) is a type II CDK2 inhibitor with K_d of 8.2 nM. AUZ 454 (K03861) inhibits CDK2 activity by competing with binding of activating cyclins.

HY-16664

SJ-172550 1 Publications Verification	MDM-2/p53 E1/E2/E3 Enzyme	Cancer
SJ-172550 is a small molecule inhibitor of MDMX; competes for the wild type p53 peptide binding to MDMX with an EC₅₀ of 5 μM.

HY-125146

BMD4503-2	Wnt	Others
BMD4503-2 is a quinoxaline derivative with inhibitory activity against LRP5/6-sclerostin interactions. BMD4503-2 restores the activity of the Wnt/β-catenin signaling pathway by competitively binding to the LRP5/6-sclerostin complex. BMD4503-2 can be used in the study of Wnt signaling pathways in bone development, maintenance and osteoporosis .

HY-126055

Hadacidin	Adenylate Cyclase	Others
Hadacidin is a competitive inhibitor of adenylate synthase. Hadacidin binds to the active site of adenylate synthase, competitively inhibiting L-aspartate binding. Hadacidin can be used in drug design, to help develop new inhibitors or activators to regulate adenylate synthase activity, and to play a role in the study of related diseases .

HY-126055A

Hadacidin sodium	Adenylate Cyclase	Others
Hadacidin sodium is a competitive inhibitor of adenylate synthase. Hadacidin sodium binds to the active site of adenylate synthase, competitively inhibiting L-aspartate binding. Hadacidin sodium can be used in drug design, to help develop new inhibitors or activators to regulate adenylate synthase activity, and to play a role in the study of related diseases .

HY-134031

Ara-ATP	DNA/RNA Synthesis	Others
Ara-ATP, a structural analog of ATP, inhibits poly(A) polymerase activity by competing with ATP .

HY-126599

Cochlioquinone A Luteoleersin	DGK	Cancer
Cochlioquinone A is a ATP-competive diacylglycerol kinase inhibitor (K_i: 3.1 μM). Cochlioquinone A can be isolated from Drechslera sacchari .

HY-P10218

MANS peptide	MARCKS PKC	Inflammation/Immunology Cancer
MANS peptide is an inhibitor for myristoylated alanine-rich C kinase substrate (MARCKS), which competes with MARCKS in cells for membrane binding, and thus inhibits the stimulation of mucin secretion and tumor metastasis .

HY-118902

Aloisine B	CDK	Others
Aloisine B (compound 9) is a cyclin-dependent kinase (CDK) inhibitor. Aloisine B inhibits cell proliferation by arresting cells in both G1 and G2 via competing with ATP-binding pocket .

HY-RI00019

hsa-miR-10226 inhibitor	MicroRNA	Cancer
hsa-miR-10226 inhibitors are chemically-modified oligonucleotides that hybridize with mature miRNAs. The miRNA inhibitors have full-length nucleotide 2'-methoxy modification. The miRNA inhibitors strongly compete with mature miRNAs to prevent the complementary pairing of miRNAs and their target genes, thereby inhibiting miRNAs from functioning.

hsa-miR-10226 inhibitor hsa-miR-10226 inhibitor

HY-RI00057

hsa-miR-107 inhibitor	MicroRNA	Cancer
hsa-miR-107 inhibitors are chemically-modified oligonucleotides that hybridize with mature miRNAs. The miRNA inhibitors have full-length nucleotide 2'-methoxy modification. The miRNA inhibitors strongly compete with mature miRNAs to prevent the complementary pairing of miRNAs and their target genes, thereby inhibiting miRNAs from functioning.

hsa-miR-107 inhibitor hsa-miR-107 inhibitor

HY-RI00064

hsa-miR-11399 inhibitor	MicroRNA	Cancer
hsa-miR-11399 inhibitors are chemically-modified oligonucleotides that hybridize with mature miRNAs. The miRNA inhibitors have full-length nucleotide 2'-methoxy modification. The miRNA inhibitors strongly compete with mature miRNAs to prevent the complementary pairing of miRNAs and their target genes, thereby inhibiting miRNAs from functioning.

hsa-miR-11399 inhibitor hsa-miR-11399 inhibitor

HY-RI00065

hsa-miR-11400 inhibitor	MicroRNA	Cancer
hsa-miR-11400 inhibitors are chemically-modified oligonucleotides that hybridize with mature miRNAs. The miRNA inhibitors have full-length nucleotide 2'-methoxy modification. The miRNA inhibitors strongly compete with mature miRNAs to prevent the complementary pairing of miRNAs and their target genes, thereby inhibiting miRNAs from functioning.

hsa-miR-11400 inhibitor hsa-miR-11400 inhibitor

HY-RI00066

hsa-miR-11401 inhibitor	MicroRNA	Cancer
hsa-miR-11401 inhibitors are chemically-modified oligonucleotides that hybridize with mature miRNAs. The miRNA inhibitors have full-length nucleotide 2'-methoxy modification. The miRNA inhibitors strongly compete with mature miRNAs to prevent the complementary pairing of miRNAs and their target genes, thereby inhibiting miRNAs from functioning.

hsa-miR-11401 inhibitor hsa-miR-11401 inhibitor

HY-RI00069

hsa-miR-1179 inhibitor	MicroRNA	Cancer
hsa-miR-1179 inhibitors are chemically-modified oligonucleotides that hybridize with mature miRNAs. The miRNA inhibitors have full-length nucleotide 2'-methoxy modification. The miRNA inhibitors strongly compete with mature miRNAs to prevent the complementary pairing of miRNAs and their target genes, thereby inhibiting miRNAs from functioning.

hsa-miR-1179 inhibitor hsa-miR-1179 inhibitor

HY-RI00072

hsa-miR-1182 inhibitor	MicroRNA	Cancer
hsa-miR-1182 inhibitors are chemically-modified oligonucleotides that hybridize with mature miRNAs. The miRNA inhibitors have full-length nucleotide 2'-methoxy modification. The miRNA inhibitors strongly compete with mature miRNAs to prevent the complementary pairing of miRNAs and their target genes, thereby inhibiting miRNAs from functioning.

hsa-miR-1182 inhibitor hsa-miR-1182 inhibitor

HY-RI00073

hsa-miR-1183 inhibitor	MicroRNA	Cancer
hsa-miR-1183 inhibitors are chemically-modified oligonucleotides that hybridize with mature miRNAs. The miRNA inhibitors have full-length nucleotide 2'-methoxy modification. The miRNA inhibitors strongly compete with mature miRNAs to prevent the complementary pairing of miRNAs and their target genes, thereby inhibiting miRNAs from functioning.

hsa-miR-1183 inhibitor hsa-miR-1183 inhibitor

HY-RI00074

hsa-miR-1184 inhibitor	MicroRNA	Cancer
hsa-miR-1184 inhibitors are chemically-modified oligonucleotides that hybridize with mature miRNAs. The miRNA inhibitors have full-length nucleotide 2'-methoxy modification. The miRNA inhibitors strongly compete with mature miRNAs to prevent the complementary pairing of miRNAs and their target genes, thereby inhibiting miRNAs from functioning.

hsa-miR-1184 inhibitor hsa-miR-1184 inhibitor

HY-RI00078

hsa-miR-1193 inhibitor	MicroRNA	Cancer
hsa-miR-1193 inhibitors are chemically-modified oligonucleotides that hybridize with mature miRNAs. The miRNA inhibitors have full-length nucleotide 2'-methoxy modification. The miRNA inhibitors strongly compete with mature miRNAs to prevent the complementary pairing of miRNAs and their target genes, thereby inhibiting miRNAs from functioning.

hsa-miR-1193 inhibitor hsa-miR-1193 inhibitor

HY-RI00079

hsa-miR-1197 inhibitor	MicroRNA	Cancer
hsa-miR-1197 inhibitors are chemically-modified oligonucleotides that hybridize with mature miRNAs. The miRNA inhibitors have full-length nucleotide 2'-methoxy modification. The miRNA inhibitors strongly compete with mature miRNAs to prevent the complementary pairing of miRNAs and their target genes, thereby inhibiting miRNAs from functioning.

hsa-miR-1197 inhibitor hsa-miR-1197 inhibitor

HY-RI00082

hsa-miR-1202 inhibitor	MicroRNA	Cancer
hsa-miR-1202 inhibitors are chemically-modified oligonucleotides that hybridize with mature miRNAs. The miRNA inhibitors have full-length nucleotide 2'-methoxy modification. The miRNA inhibitors strongly compete with mature miRNAs to prevent the complementary pairing of miRNAs and their target genes, thereby inhibiting miRNAs from functioning.

hsa-miR-1202 inhibitor hsa-miR-1202 inhibitor

HY-RI00083

hsa-miR-1203 inhibitor	MicroRNA	Cancer
hsa-miR-1203 inhibitors are chemically-modified oligonucleotides that hybridize with mature miRNAs. The miRNA inhibitors have full-length nucleotide 2'-methoxy modification. The miRNA inhibitors strongly compete with mature miRNAs to prevent the complementary pairing of miRNAs and their target genes, thereby inhibiting miRNAs from functioning.

hsa-miR-1203 inhibitor hsa-miR-1203 inhibitor

HY-RI00084

hsa-miR-1204 inhibitor	MicroRNA	Cancer
hsa-miR-1204 inhibitors are chemically-modified oligonucleotides that hybridize with mature miRNAs. The miRNA inhibitors have full-length nucleotide 2'-methoxy modification. The miRNA inhibitors strongly compete with mature miRNAs to prevent the complementary pairing of miRNAs and their target genes, thereby inhibiting miRNAs from functioning.

hsa-miR-1204 inhibitor hsa-miR-1204 inhibitor

HY-RI00085

hsa-miR-1205 inhibitor	MicroRNA	Cancer
hsa-miR-1205 inhibitors are chemically-modified oligonucleotides that hybridize with mature miRNAs. The miRNA inhibitors have full-length nucleotide 2'-methoxy modification. The miRNA inhibitors strongly compete with mature miRNAs to prevent the complementary pairing of miRNAs and their target genes, thereby inhibiting miRNAs from functioning.

hsa-miR-1205 inhibitor hsa-miR-1205 inhibitor

HY-RI00088

hsa-miR-1208 inhibitor	MicroRNA	Cancer
hsa-miR-1208 inhibitors are chemically-modified oligonucleotides that hybridize with mature miRNAs. The miRNA inhibitors have full-length nucleotide 2'-methoxy modification. The miRNA inhibitors strongly compete with mature miRNAs to prevent the complementary pairing of miRNAs and their target genes, thereby inhibiting miRNAs from functioning.

hsa-miR-1208 inhibitor hsa-miR-1208 inhibitor

HY-RI00089

hsa-miR-12113 inhibitor	MicroRNA	Cancer
hsa-miR-12113 inhibitors are chemically-modified oligonucleotides that hybridize with mature miRNAs. The miRNA inhibitors have full-length nucleotide 2'-methoxy modification. The miRNA inhibitors strongly compete with mature miRNAs to prevent the complementary pairing of miRNAs and their target genes, thereby inhibiting miRNAs from functioning.

hsa-miR-12113 inhibitor hsa-miR-12113 inhibitor

HY-RI00090

hsa-miR-12114 inhibitor	MicroRNA	Cancer
hsa-miR-12114 inhibitors are chemically-modified oligonucleotides that hybridize with mature miRNAs. The miRNA inhibitors have full-length nucleotide 2'-methoxy modification. The miRNA inhibitors strongly compete with mature miRNAs to prevent the complementary pairing of miRNAs and their target genes, thereby inhibiting miRNAs from functioning.

hsa-miR-12114 inhibitor hsa-miR-12114 inhibitor

HY-RI00091

hsa-miR-12115 inhibitor	MicroRNA	Cancer
hsa-miR-12115 inhibitors are chemically-modified oligonucleotides that hybridize with mature miRNAs. The miRNA inhibitors have full-length nucleotide 2'-methoxy modification. The miRNA inhibitors strongly compete with mature miRNAs to prevent the complementary pairing of miRNAs and their target genes, thereby inhibiting miRNAs from functioning.

hsa-miR-12115 inhibitor hsa-miR-12115 inhibitor

HY-RI00092

hsa-miR-12116 inhibitor	MicroRNA	Cancer
hsa-miR-12116 inhibitors are chemically-modified oligonucleotides that hybridize with mature miRNAs. The miRNA inhibitors have full-length nucleotide 2'-methoxy modification. The miRNA inhibitors strongly compete with mature miRNAs to prevent the complementary pairing of miRNAs and their target genes, thereby inhibiting miRNAs from functioning.

hsa-miR-12116 inhibitor hsa-miR-12116 inhibitor

HY-RI00093

hsa-miR-12117 inhibitor	MicroRNA	Cancer
hsa-miR-12117 inhibitors are chemically-modified oligonucleotides that hybridize with mature miRNAs. The miRNA inhibitors have full-length nucleotide 2'-methoxy modification. The miRNA inhibitors strongly compete with mature miRNAs to prevent the complementary pairing of miRNAs and their target genes, thereby inhibiting miRNAs from functioning.

hsa-miR-12117 inhibitor hsa-miR-12117 inhibitor

HY-RI00094

hsa-miR-12118 inhibitor	MicroRNA	Cancer
hsa-miR-12118 inhibitors are chemically-modified oligonucleotides that hybridize with mature miRNAs. The miRNA inhibitors have full-length nucleotide 2'-methoxy modification. The miRNA inhibitors strongly compete with mature miRNAs to prevent the complementary pairing of miRNAs and their target genes, thereby inhibiting miRNAs from functioning.

hsa-miR-12118 inhibitor hsa-miR-12118 inhibitor

HY-RI00095

hsa-miR-12119 inhibitor	MicroRNA	Cancer
hsa-miR-12119 inhibitors are chemically-modified oligonucleotides that hybridize with mature miRNAs. The miRNA inhibitors have full-length nucleotide 2'-methoxy modification. The miRNA inhibitors strongly compete with mature miRNAs to prevent the complementary pairing of miRNAs and their target genes, thereby inhibiting miRNAs from functioning.

hsa-miR-12119 inhibitor hsa-miR-12119 inhibitor

HY-RI00096

hsa-miR-12120 inhibitor	MicroRNA	Cancer
hsa-miR-12120 inhibitors are chemically-modified oligonucleotides that hybridize with mature miRNAs. The miRNA inhibitors have full-length nucleotide 2'-methoxy modification. The miRNA inhibitors strongly compete with mature miRNAs to prevent the complementary pairing of miRNAs and their target genes, thereby inhibiting miRNAs from functioning.

hsa-miR-12120 inhibitor hsa-miR-12120 inhibitor

HY-RI00097

hsa-miR-12121 inhibitor	MicroRNA	Cancer
hsa-miR-12121 inhibitors are chemically-modified oligonucleotides that hybridize with mature miRNAs. The miRNA inhibitors have full-length nucleotide 2'-methoxy modification. The miRNA inhibitors strongly compete with mature miRNAs to prevent the complementary pairing of miRNAs and their target genes, thereby inhibiting miRNAs from functioning.

hsa-miR-12121 inhibitor hsa-miR-12121 inhibitor

HY-RI00098

hsa-miR-12122 inhibitor	MicroRNA	Cancer
hsa-miR-12122 inhibitors are chemically-modified oligonucleotides that hybridize with mature miRNAs. The miRNA inhibitors have full-length nucleotide 2'-methoxy modification. The miRNA inhibitors strongly compete with mature miRNAs to prevent the complementary pairing of miRNAs and their target genes, thereby inhibiting miRNAs from functioning.

hsa-miR-12122 inhibitor hsa-miR-12122 inhibitor

HY-RI00099

hsa-miR-12123 inhibitor	MicroRNA	Cancer
hsa-miR-12123 inhibitors are chemically-modified oligonucleotides that hybridize with mature miRNAs. The miRNA inhibitors have full-length nucleotide 2'-methoxy modification. The miRNA inhibitors strongly compete with mature miRNAs to prevent the complementary pairing of miRNAs and their target genes, thereby inhibiting miRNAs from functioning.

hsa-miR-12123 inhibitor hsa-miR-12123 inhibitor

HY-RI00100

hsa-miR-12124 inhibitor	MicroRNA	Cancer
hsa-miR-12124 inhibitors are chemically-modified oligonucleotides that hybridize with mature miRNAs. The miRNA inhibitors have full-length nucleotide 2'-methoxy modification. The miRNA inhibitors strongly compete with mature miRNAs to prevent the complementary pairing of miRNAs and their target genes, thereby inhibiting miRNAs from functioning.

hsa-miR-12124 inhibitor hsa-miR-12124 inhibitor

HY-RI00101

hsa-miR-12125 inhibitor	MicroRNA	Cancer
hsa-miR-12125 inhibitors are chemically-modified oligonucleotides that hybridize with mature miRNAs. The miRNA inhibitors have full-length nucleotide 2'-methoxy modification. The miRNA inhibitors strongly compete with mature miRNAs to prevent the complementary pairing of miRNAs and their target genes, thereby inhibiting miRNAs from functioning.

hsa-miR-12125 inhibitor hsa-miR-12125 inhibitor

HY-RI00102

hsa-miR-12126 inhibitor	MicroRNA	Cancer
hsa-miR-12126 inhibitors are chemically-modified oligonucleotides that hybridize with mature miRNAs. The miRNA inhibitors have full-length nucleotide 2'-methoxy modification. The miRNA inhibitors strongly compete with mature miRNAs to prevent the complementary pairing of miRNAs and their target genes, thereby inhibiting miRNAs from functioning.

hsa-miR-12126 inhibitor hsa-miR-12126 inhibitor

HY-RI00103

hsa-miR-12127 inhibitor	MicroRNA	Cancer
hsa-miR-12127 inhibitors are chemically-modified oligonucleotides that hybridize with mature miRNAs. The miRNA inhibitors have full-length nucleotide 2'-methoxy modification. The miRNA inhibitors strongly compete with mature miRNAs to prevent the complementary pairing of miRNAs and their target genes, thereby inhibiting miRNAs from functioning.

hsa-miR-12127 inhibitor hsa-miR-12127 inhibitor

HY-RI00104

hsa-miR-12128 inhibitor	MicroRNA	Cancer
hsa-miR-12128 inhibitors are chemically-modified oligonucleotides that hybridize with mature miRNAs. The miRNA inhibitors have full-length nucleotide 2'-methoxy modification. The miRNA inhibitors strongly compete with mature miRNAs to prevent the complementary pairing of miRNAs and their target genes, thereby inhibiting miRNAs from functioning.

hsa-miR-12128 inhibitor hsa-miR-12128 inhibitor

HY-RI00105

hsa-miR-12129 inhibitor	MicroRNA	Cancer
hsa-miR-12129 inhibitors are chemically-modified oligonucleotides that hybridize with mature miRNAs. The miRNA inhibitors have full-length nucleotide 2'-methoxy modification. The miRNA inhibitors strongly compete with mature miRNAs to prevent the complementary pairing of miRNAs and their target genes, thereby inhibiting miRNAs from functioning.

hsa-miR-12129 inhibitor hsa-miR-12129 inhibitor

HY-RI00106

hsa-miR-12130 inhibitor	MicroRNA	Cancer
hsa-miR-12130 inhibitors are chemically-modified oligonucleotides that hybridize with mature miRNAs. The miRNA inhibitors have full-length nucleotide 2'-methoxy modification. The miRNA inhibitors strongly compete with mature miRNAs to prevent the complementary pairing of miRNAs and their target genes, thereby inhibiting miRNAs from functioning.

hsa-miR-12130 inhibitor hsa-miR-12130 inhibitor

HY-RI00107

hsa-miR-12131 inhibitor	MicroRNA	Cancer
hsa-miR-12131 inhibitors are chemically-modified oligonucleotides that hybridize with mature miRNAs. The miRNA inhibitors have full-length nucleotide 2'-methoxy modification. The miRNA inhibitors strongly compete with mature miRNAs to prevent the complementary pairing of miRNAs and their target genes, thereby inhibiting miRNAs from functioning.

hsa-miR-12131 inhibitor hsa-miR-12131 inhibitor

HY-RI00108

hsa-miR-12132 inhibitor	MicroRNA	Cancer
hsa-miR-12132 inhibitors are chemically-modified oligonucleotides that hybridize with mature miRNAs. The miRNA inhibitors have full-length nucleotide 2'-methoxy modification. The miRNA inhibitors strongly compete with mature miRNAs to prevent the complementary pairing of miRNAs and their target genes, thereby inhibiting miRNAs from functioning.

hsa-miR-12132 inhibitor hsa-miR-12132 inhibitor

HY-RI00109

hsa-miR-12133 inhibitor	MicroRNA	Cancer
hsa-miR-12133 inhibitors are chemically-modified oligonucleotides that hybridize with mature miRNAs. The miRNA inhibitors have full-length nucleotide 2'-methoxy modification. The miRNA inhibitors strongly compete with mature miRNAs to prevent the complementary pairing of miRNAs and their target genes, thereby inhibiting miRNAs from functioning.

hsa-miR-12133 inhibitor hsa-miR-12133 inhibitor

HY-RI00110

hsa-miR-12135 inhibitor	MicroRNA	Cancer
hsa-miR-12135 inhibitors are chemically-modified oligonucleotides that hybridize with mature miRNAs. The miRNA inhibitors have full-length nucleotide 2'-methoxy modification. The miRNA inhibitors strongly compete with mature miRNAs to prevent the complementary pairing of miRNAs and their target genes, thereby inhibiting miRNAs from functioning.

hsa-miR-12135 inhibitor hsa-miR-12135 inhibitor

HY-RI00111

hsa-miR-12136 inhibitor	MicroRNA	Cancer
hsa-miR-12136 inhibitors are chemically-modified oligonucleotides that hybridize with mature miRNAs. The miRNA inhibitors have full-length nucleotide 2'-methoxy modification. The miRNA inhibitors strongly compete with mature miRNAs to prevent the complementary pairing of miRNAs and their target genes, thereby inhibiting miRNAs from functioning.

hsa-miR-12136 inhibitor hsa-miR-12136 inhibitor